Sachdeva Sonia, Grover Vishakha, Malhotra Ranjan, Kapoor Anoop, Mohanty Kanishk
Sai Dental Clinic and Implant Centre, Jalandhar, Punjab, India.
Department of Periodontology and Oral Implantology, Dr. H. S. J. Institute of Dental Sciences and Hospital, Punjab University, Chandigarh, India.
J Indian Soc Periodontol. 2018 Nov-Dec;22(6):523-528. doi: 10.4103/jisp.jisp_252_18.
Local drug delivery is most commonly used as an adjunct to scaling and root planing (SRP) for the treatment of periodontal disease. Varied success rates have been documented for various vehicles used for intrasite delivery of active therapeutic agents. Recently, varnishes acting as a reservoir of chlorhexidine have shown potential for the management of chronic periodontitis patients. The aim of the present investigation was a comparative evaluation of the clinical effectiveness of single and multiple applications of 1% chlorhexidine and thymol varnish (Cervitec Plus) along with SRP in patients with chronic periodontitis.
The present study included 30 patients with chronic periodontitis divided into three groups based on the number of subgingival applications of chlorhexidine varnish single application (Group A), two applications at a week's interval (Group B), and three applications with 7-day interval in between two applications (Group C). Clinical parameters, namely plaque index (PI), sulcus bleeding index, probing pocket depth (PPD), and relative attachment level (RAL) were recorded at baseline, 1 month and 3 months in all three groups to compare the clinical efficacy.
A statistically significant reduction was observed in PI, sulcus bleeding index, PPD, and RAL at 1 and 3 months in all the three groups. Greater (though statistically nonsignificant) improvements were observed in Groups B and C.
Within limitations of the study, it can be concluded that multiple applications of 1% chlorhexidine and thymol varnish (Cervitec Plus) have an added benefit over the single application in the treatment of chronic periodontitis.
局部药物递送最常用于作为龈下刮治术和根面平整术(SRP)的辅助手段来治疗牙周疾病。已记录了用于活性治疗剂局部递送的各种载体的不同成功率。最近,作为洗必泰储库的清漆已显示出对慢性牙周炎患者管理的潜力。本研究的目的是对1%洗必泰百里酚清漆(Cervitec Plus)单次和多次应用联合SRP治疗慢性牙周炎患者的临床有效性进行比较评估。
本研究纳入30例慢性牙周炎患者,根据洗必泰清漆的龈下应用次数分为三组:单次应用(A组)、间隔一周应用两次(B组)、两次应用之间间隔7天应用三次(C组)。在所有三组的基线、1个月和3个月时记录临床参数,即菌斑指数(PI)、龈沟出血指数、探诊深度(PPD)和相对附着水平(RAL),以比较临床疗效。
在所有三组中,1个月和3个月时PI、龈沟出血指数、PPD和RAL均有统计学意义的降低。B组和C组有更大(尽管无统计学意义)的改善。
在本研究的局限性范围内,可以得出结论,1%洗必泰百里酚清漆(Cervitec Plus)多次应用在慢性牙周炎治疗中比单次应用有额外益处。